Boston Scientific (BSX) vs 3M (MMM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
3M (MMM) has outperformed Boston Scientific (BSX) over the past year, gaining 5.9% versus a loss of 56.7%. Over five years, MMM leads with a +21.3% price change compared with +8.8% for BSX. 3M is the larger company by market cap ($91.97 billion vs $60.85 billion), about 1.5 times the size, while Boston Scientific is growing revenue faster (+19.9% vs +1.5%).
On valuation, Boston Scientific trades at a lower forward P/E (13.4x vs 17.9x for 3M). 3M pays a dividend yielding 1.72%, while Boston Scientific does not currently pay one. Boston Scientific converts more of its revenue into profit, with a net margin of 14.4% versus 13.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSX | MMM |
|---|---|---|
| Share price | $41.98 | $177.99 |
| Market cap | $60.85B | $91.97B |
| 1-day change | -2.35% | -0.27% |
| YTD return | -55.97% | +11.17% |
| 1-year return | -56.67% | +5.89% |
| 5-year return | +8.84% | +21.28% |
| P/E ratio (TTM) | 17.71 | 26.57 |
| Forward P/E | 13.41 | 17.94 |
| EPS (TTM) | $2.37 | $6.70 |
| Dividend yield | 0.00% | 1.72% |
| Annual dividend | $0.00 | $3.07 |
| Revenue (latest FY) | $20.07B | $24.95B |
| Revenue growth (YoY) | +19.87% | +1.52% |
| Net income (latest FY) | $2.89B | $3.25B |
| Gross margin | 69.01% | 39.91% |
| Operating margin | 18.00% | 18.55% |
| Net margin | 14.41% | 13.03% |
| 52-week high | $101.91 | $196.90 |
| 52-week low | $39.57 | $139.34 |
| Distance from 52-week high | -58.81% | -9.60% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +18.15% | +9.00% |
| Average volume | 19.19M | 3.28M |
| Shares outstanding | 1.45B | 516.73M |
| Employees | 59,000 | 60,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MMM has outperformed BSX by 62.6 percentage points over the past year.
- 3M trades at a higher earnings multiple (26.6x vs 17.7x trailing P/E).
- 3M offers a meaningfully higher dividend yield (1.72% vs 0.00%).
- Boston Scientific grew revenue faster in its latest fiscal year (+19.87% vs +1.52%).
About Boston Scientific
BSX stock →Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Health Care · Medical/Dental Instruments · 59,000 employees
About 3M
MMM stock →3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer.
Health Care · Medical/Dental Instruments · 60,500 employees
BSX vs MMM FAQ
Which is bigger, Boston Scientific or 3M?
3M (MMM) is larger, with a market capitalization of $91.97B compared with $60.85B for Boston Scientific (BSX).
Which stock has performed better over the past year, BSX or MMM?
MMM returned +5.89% over the past 12 months, compared with -56.67% for BSX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BSX or MMM?
BSX has the lower trailing P/E at 17.7, versus 26.6 for MMM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Boston Scientific or 3M?
3M pays a dividend yielding 1.72%, while Boston Scientific does not currently pay a regular dividend.
Are Boston Scientific and 3M in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.